2025-05-27 - Analysis Report
Okay, here's an analysis of Merck & Co Inc (MRK) based on the data provided, presented in a structured format with key metrics first, followed by analysis:

## MRK Stock Analysis

**Company Overview:** Merck & Co Inc is a global pharmaceutical company that develops and manufactures a wide range of healthcare products.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** -0.45%
*   **VOO Cumulative Return:** 79.45%
*   **Absolute Difference:** -79.9%
*   **Relative Difference Percentile:** 4.9% (Indicates MRK's underperformance is near the lower end of its historical range compared to VOO)

**Analysis:** MRK significantly underperformed the S&P 500 (VOO) over the period considered. The relative difference percentile suggests that this level of underperformance, while substantial, is not unprecedented in the company's recent history (as compared to VOO).

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 5.0%   | 58.4%  | -24.0%  | 0.0    | 108.3  |
| 2016-2018  | 42.0%  | 66.6%  | 24.0%   | 0.1    | 151.6  |
| 2017-2019  | 40.0%  | 66.6%  | 11.0%   | 0.2    | 185.4  |
| 2018-2020  | 19.0%  | 66.6%  | -6.0%   | 0.4    | 172.0  |
| 2019-2021  | -1.0%  | 65.6%  | -55.0%  | 0.5    | 175.1  |
| 2020-2022  | 13.0%  | 69.3%  | 7.0%    | 0.5    | 261.6  |
| 2021-2023  | 35.0%  | 69.3%  | 19.0%   | 0.3    | 264.2  |
| 2022-2024  | -6.0%  | 69.3%  | -23.0%  | 0.3    | 247.7  |
| 2023-2025  | -53.0% | 70.3%  | -81.0%  | 0.4    | 194.8  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows fluctuating performance over the years, with significant declines in the most recent periods (2022-2024 and 2023-2025).
*   **MDD:** The Maximum Drawdown (MDD) remains high, indicating significant risk.
*   **Alpha:** Alpha values are negative for the most recent periods, suggesting that the stock has underperformed relative to its benchmark (risk-adjusted performance).
*   **Beta:** Beta values are relatively low, indicating that the stock is less sensitive to market movements.

### 2. Recent Price Action

*   **Current Price:** 77.58
*   **Previous Close:** 77.84
*   **Price Change:** -0.33
*   **5-Day Moving Average:** 77.52
*   **20-Day Moving Average:** 79.1575
*   **60-Day Moving Average:** 84.391

**Analysis:** The current price is slightly down from the previous close. All the moving averages are trending downwards, indicating a downtrend. The price is below the 20-day and 60-day moving averages, further confirming the downtrend.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 39.51 (Approaching Oversold)
*   **PPO:** 0.2574
*   **Hybrid Signal:** cash_1%_Buy 80% of cash (35 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Difference Change:** 4.9 (+) (Short-term increase)
*   **Expected Return (%):** -212.1% (Long-term underperformance vs. S&P 500)

**Analysis:**

*   **MRI:** The MRI suggests relatively low market risk.
*   **RSI:** The RSI is below 40, indicating that the stock is approaching oversold conditions, which could signal a potential reversal or bounce.
*   **PPO:** The PPO suggests the stock is trending downwards.
*   **Hybrid Signal:** The hybrid signal is issuing a buy signal, but with caution due to the MRI.
*   **Relative Difference Change:** The recent increase in the relative difference may indicate a short-term improvement in performance compared to the benchmark, though it's from a low base.
*   **Expected Return:** The very negative expected return suggests significant projected underperformance relative to the S&P 500 in the long term.
*   **Price Change:** The small change from the previous close indicates a lack of strong momentum.

### 4. Recent News & Events

*   **[2025-05-27]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-24]:** Analyst discussions regarding recent performance and industry trends.
*   **[2025-05-25]:** Notable stock volatility.
*   **[2025-05-23]:** Highlighted risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news suggests that MRK is experiencing volatility and is subject to market discussions, potentially due to significant events. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis:

| 날짜         | EPS  | 매출         |
|--------------|------|--------------|
| 2025-05-02   | 2.01 | 15.53 B$     |
| 2024-11-06   | 1.25 | 16.66 B$     |
| 2024-08-05   | 2.15 | 16.11 B$     |
| 2024-05-03   | 1.88 | 15.78 B$     |
| 2025-05-02   | 1.88 | 15.78 B$     |

**Analysis:**

*   **EPS:** Fluctuating EPS values suggest inconsistent profitability.
*   **Revenue:** The revenue has varied slightly over the quarters.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $15.53B   | 77.98%        |
| 2024-12-31   | $15.62B   | 75.50%        |
| 2024-09-30   | $16.66B   | 75.51%        |
| 2024-06-30   | $16.11B   | 76.76%        |
| 2024-03-31   | $15.78B   | 77.56%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-03-31   | $48.34B   | 10.51% |
| 2024-12-31   | $46.31B   | 8.08%  |
| 2024-09-30   | $44.50B   | 7.09%  |
| 2024-06-30   | $43.58B   | 12.52% |
| 2024-03-31   | $40.36B   | 11.80% |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue has shown some fluctuation, and the profit margin remains consistently high, indicating good profitability.
*   **Capital and Profitability:** Equity has generally increased over the quarters, and ROE has varied but remains at decent levels, suggesting that the company is effectively using its equity to generate profits.

### 7. Overall Assessment

Based on the data provided, here's a summary assessment of MRK:

*   **Underperformance:** MRK has significantly underperformed the S&P 500, with a substantial negative cumulative return difference.
*   **Downtrend:** The stock is currently in a downtrend, as indicated by moving averages and recent price action.
*   **Technical Indicators:** The RSI suggests it's approaching oversold territory, while the MRI shows low market risk, and the hybrid signal suggests a buy with caution.
*   **News:** Recent news indicates volatility and potential significant events that investors should monitor.
*   **Earnings:** Recent earnings and financial data show fluctuating revenue and EPS, but strong profit margins and generally increasing equity.
*   **Expected Return:** The significantly negative expected return relative to the S&P 500 should be noted.

**Conclusion:**

MRK is currently facing challenges, as evidenced by its underperformance and downtrend. The technical indicators suggest a potential for a rebound, but investors should be cautious and consider the negative long-term expected return. Recent news and company announcements should be closely monitored. The company's financials remain relatively strong, but the underperformance relative to the broader market is a concern.
